Theranostic nanoparticles (TNPs) are a rapidly emerging class of nanomaterials that combine therapeutic and diagnostic properties. TNPs are designed to integrate both therapeutic and diagnostic functions into a single platform, allowing for the delivery of drugs, imaging agents, and other bioactive molecules simultaneously. This has the potential to dramatically improve the efficacy and safety of treatments and the accuracy of diagnoses. TNPs are composed of a biocompatible nanocarrier, such as a lipid or polymer, which can be loaded with various molecules that can be used for detection and treatment. For example, TNPs can be loaded with a diagnostic agent such as a fluorescent dye or an imaging agent such as a radioactive isotope. These particles can also be loaded with a therapeutic agent, such as an anticancer drug, to provide targeted treatment. TNPs have many advantages over traditional therapies, including enhanced safety and efficacy, improved target specificity, and reduced side effects. They also have the potential to provide personalized medicine, as they can be tailored to individual patient needs. TNPs also have the potential to reduce the cost of healthcare, as their targeted delivery reduces the amount of drug needed to achieve therapeutic effects. TNPs are still in the early stages of development, and many challenges remain before they can be widely used in clinical settings. These challenges include improving their stability in the body, reducing their toxicity, and developing more efficient delivery methods. Despite these challenges, TNPs offer promise for the future of personalized medicine, and researchers are actively exploring new applications and improving current technologies
Metal nanoclusters (MNCs) have attracted considerable attention in the fields of catalysis and biomedicine due to their ultrasmall size, unique molecular-like properties, rich surface chemistry, good…
NIR-active up-conversion nano-phosphors (UCNPs) based on rare earth ions doped hexagonal β-NaYF 4 nanoparticles are of particular interest since they offer the highest quantum yield of up-conversion…
Participants can earn 1 CPD credit for each hour of attendance.
Oral and poster slots for original Theranostic Nanoparticles work, reviewed by the scientific committee.
Meet nanotechnologists, researchers, scientists and engineers from around the world across three days.
In-person and virtual registrations include an electronic copy of the abstract book.
Plenary lectures from leading voices shaping Theranostic Nanoparticles research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Theranostic Nanoparticles track is a dedicated stream within World Nano 2027 covering the latest research, innovation, and best practice in Theranostic Nanoparticles. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Nanotechnology researchers, scientists and engineers, educators and students with an interest in Theranostic Nanoparticles are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.
Yes. World Nano 2027 is a hybrid conference — attend the Theranostic Nanoparticles track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Attend without presenting.
